Cytecom Ltd
Solution Type
Antimicrobial Stewardship, Diagnostics
Pathogens Addressed
Bacteria, Fungi, Yeasts
Sectors Served
Human Health, Veterinary
Overview
Cytecom is a Leeds-based biotechnology company developing novel anti-biofilm and antimicrobial compounds for treatment of drug-resistant infections associated with medical devices and implants. Biofilm-associated infections are among the most resistant clinical challenges , conventional antibiotics are largely ineffective against established biofilms. Cytecom\'s compounds target the biofilm matrix directly, disrupting resistant bacterial communities in catheter, joint replacement, and implant-related infections.
Stay Updated
Stay connected so that you don't miss the latest AMR insights and updates.